CyPlex is a fully automated, multi-analyte bench top immunoassay system featuring a microfluidic cartridge that allows the analysis of multiple biomarkers from very small amounts of biological samples, as well as an analyser. The system provides "sample-to-answer" accurate test results in a sealed disposable device, which makes it useful for multiple clinical applications and routine life sciences research.
SBH Sciences president and chief science officer, Dr. Raphael Nir, noted that the company is the first contract research organisation to offer the CyPlex system to its customers.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia